Uncategorized
Favorable long-term outcomes achieved with fixed-interval anti-VEGF dosing
At the American Society of Retina Specialists meeting in San Diego, Marc Peden, MD, discusses his presentation of long-term visual outcomes of patients receiving continuous, fixed-interval dosing of Lucentis.